Celsis International,, Ltd.
600 W. Chicago Ave., Suite 625
Chicago, IL 60654-2822
(312) 476 1200
http://www.celsis.com
DIRECTIONS
Celsis International Ltd is a world-leading provider of innovative life science products and contract lab services to the pharmaceutical and consumer products industries through its three areas of focus; rapid microbial detection systems, analytical laboratory services and ADME-Tox in vitro research products. Celsis' customers include all 25 of the top global pharmaceutical companies and leading manufacturers of cosmetics; personal care and home care products; nutritional, sports and juice beverages; shelf-stable UHT/ESL food and dairy products; and more. Each division of Celsis delivers substantial time and cost savings to its customers, in addition to ensuring product quality and safety for consumers. Celsis | Rapid Detection division helps manufacturers worldwide reduce production cycle times and reduce working capital and inventory requirements by enabling customers to release products to market faster. A proprietary enzyme assay determines the absence or presence of microbial contamination in as few as 18 hours, instead of an average of 5 days, resulting in significant financial savings. Celsis | Analytical Services division provides cost effective, outsourced CGMP laboratory testing services to industry, serving pharmaceutical, biopharmaceutical and consumer products companies from two FDA-audited and accredited facilities in St. Louis and New Jersey. Expertise in analytical chemistry (instrumentation includes HPLC, MS, IC, GS, AA, etc.) and biological sciences to stability storage and testing. Celsis | In Vitro Technologies (Celsis IVT) provides a broad range of cellular and sub-cellular products to help researchers cost-effectively, quickly and reliably screen compounds for their ADME-Tox properties early in the drug discovery and development process, thereby reducing the time and cost of further development or trial on those compounds which will not be properly metabolized or which may cause serious drug-drug interactions.
EST. Employees: 200
EST. Sales (mil.): $52.1
.
No comments:
Post a Comment